Cooper Research and Development Expenses 2012-2026 | COO

Cooper annual/quarterly research and development expenses history and growth rate from 2012 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Cooper research and development expenses for the quarter ending April 30, 2026 were $0.043B, a 6.59% decline year-over-year.
  • Cooper research and development expenses for the twelve months ending April 30, 2026 were $0.173B, a 6.08% increase year-over-year.
  • Cooper annual research and development expenses for 2025 were $0.172B, a 11.03% increase from 2024.
  • Cooper annual research and development expenses for 2024 were $0.155B, a 12.88% increase from 2023.
  • Cooper annual research and development expenses for 2023 were $0.137B, a 24.57% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Cooper Annual Research and Development Expenses
(Millions of US $)
2025 $172
2024 $155
2023 $137
2022 $110
2021 $93
2020 $93
2019 $87
2018 $85
2017 $69
2016 $65
2015 $70
2014 $66
2013 $59
2012 $52
2011 $44
Cooper Quarterly Research and Development Expenses
(Millions of US $)
2026-04-30 $43
2026-01-31 $44
2025-10-31 $41
2025-07-31 $45
2025-04-30 $46
2025-01-31 $41
2024-10-31 $38
2024-07-31 $39
2024-04-30 $39
2024-01-31 $40
2023-10-31 $37
2023-07-31 $37
2023-04-30 $33
2023-01-31 $32
2022-10-31 $29
2022-07-31 $29
2022-04-30 $26
2022-01-31 $26
2021-10-31 $26
2021-07-31 $25
2021-04-30 $21
2021-01-31 $21
2020-10-31 $26
2020-07-31 $22
2020-04-30 $24
2020-01-31 $22
2019-10-31 $23
2019-07-31 $22
2019-04-30 $21
2019-01-31 $21
2018-10-31 $23
2018-07-31 $23
2018-04-30 $21
2018-01-31 $19
2017-10-31 $19
2017-07-31 $18
2017-04-30 $17
2017-01-31 $16
2016-10-31 $18
2016-07-31 $16
2016-04-30 $17
2016-01-31 $15
2015-10-31 $18
2015-07-31 $18
2015-04-30 $17
2015-01-31 $16
2014-10-31 $18
2014-07-31 $16
2014-04-30 $16
2014-01-31 $16
2013-10-31 $16
2013-07-31 $15
2013-04-30 $14
2013-01-31 $14
2012-10-31 $14
2012-07-31 $13
2012-04-30 $13
2012-01-31 $11
2011-10-31 $12
2011-07-31 $12
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.894B $4.092B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00